In Vivo Imaging Systems Market

In Vivo Imaging Systems Market: Global Industry Analysis and Opportunity Assessment 2016-2026

  • Ongoing
  • February 2020
  • REP-GB-1742
  • PDF PPT EXCEL
In Vivo Imaging Systems Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This In Vivo Imaging Systems market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving In Vivo Imaging Systems market.


In vivo imaging system can be broken down into in vivo which means performed in living organism and imaging systems which means visual representation system. In other words it can be defined as the technique used for biological imaging in order to study the cellular activity and the effects of drugs in various diseases. It can be subdivided into morphological imaging systems and molecular imaging systems.  High-frequency micro-ultrasound, computed tomography (CT) scan and magnetic resonance imaging (MRI) constitute to morphological imaging systems whereas fluorescence, bioluminescence, single photon emission computed tomography (SPECT) and positron emission tomography (PET) constitute to Molecular Imaging systems. In vivo Imaging systems can be used for both animals and Humans depending upon the purpose of use. Usually in vivo imaging systems are used in research laboratories to study the activity of a drug on the animals like albino mice albino rats etc. These small animal imaging consist of full body scan and targeted scan. Full body scan is popularly followed imaging method as it is economic and hence can be used for commercialization and regular validation of new drugs. Small animal In vivo imaging includes the measurement and classification of molecular level biological process that are used to study the specific targeted drugs. Small animal In vivo imaging consist of micro MRI, micro CT, micro PET, micro SPECT, digital angiography, x-ray imaging and magnetic particle imaging. Human In vivo Imaging systems are used to study the deformity or the disorder caused to the humans that may be disease induced, congenital or trauma induced. The imaging systems used here are similar to that in animals like CT Scan, PET scan, SPECT scan, MRI scan etc.

In vivo Imaging Systems Market: Drivers and Restraints

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Need granular data and specific insights that are hard to get?
/p>

Technological advancement of imaging systems, rise in the rate of adoption of multi-modality imaging systems in clinical and preclinical research studies, growth in the acceptance of preclinical imaging for drug discovery and development process, growing awareness about the benefits of early disease diagnosis are some of the crucial parameters driving the current Imaging markets.  A number of factors such as high implementation cost of sophisticated clinical and preclinical imaging systems, High cost of maintenance, low life span of accessories used are restricting the growth of the global imaging market.

In vivo Imaging Systems Market: Segmentation

In vivo Imaging Systems Market: Overview

The in vivo market has some well establish technology, but on and off there are some of the technological advancement taking place in the market. In case of MRI the currently used technology for diagnostic purpose ranges from 1.5 T to 3 T, for human clinical studies 9.4 T and animal clinical studies 21. T.

The combination of PET-MRI at 9.4 T is operational since 2009, but presently only brain can be imaged such high magnetic field strengths.

In vivo Imaging Systems Market: Region-wise Outlook

North America market is a leader for In vivo imaging systems followed by the European market.  Research Institutes and Pharmaceutical companies, growing usage for in vivo imaging system and technological advancements, rising awareness and applications of functional imaging that are factors driving market growth. Asia-Pacific market is also growing at fastest pace due to growing number of research institutes, increasing number of funds given by government for research and rising industry-academia partnerships for small animal research and increasing medical tourism.

In vivo Imaging Systems Market: Key Players

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications. The key players in the in vivo imaging system market include Bruker Corporation, Life Technologies Corporation, Miltenyi Viotech GmbH, Biosacan, Inc., Gamma Meddica, Targeson, Inc., Sanco Medical, Aspect Imaging, Mediso Medical Imaging Systems, Perkin Elmer, Inc., FUJIFILM Holdings Corporation and Siemens AG.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key In Vivo Imaging Systems Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Based on application, the In vivo Imaging Systems Market is segmented into the following:

  • Monitoring Drug Treatment Response
  • Bio Distribution Studies
  • Cancer Cell Detection
  • Biomarkers
  • Longitudinal Studies
  • Epigenetics

Based on technology, In vivo Imaging Systems Market is segmented into the following:

  • Magnetic Resonance Imaging (MRI)
  • Digital Angiography
  • Ultrasound
  • Nuclear Imaging
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computerized Tomography (SPECT)
  • Optical Imaging (OI)
    • Bioluminescence Imaging
    • Cerenkov Luminescence Imaging
  • Others
    • Ultrasound Imaging
    • Computerized Tomography (CT)

Based on end user, the in vivo imaging systems market can be segmented into following:

  • Hospitals
  • Clinics
  • Pharmaceutical Research Institutes
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Educational research institutes

Based on geography, the in vivo Imaging Systems market is segmented into following:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
  • Eastern Europe (Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa)

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Western Europe (Germany, Italy, Spain, France, U.K, Rest Of Western Europe)
  • Eastern Europe (Poland, Russia, Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC countries, S. Africa, Rest of MEA)

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology